This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,064.99 fixed-price delivery order covers the supply of PEGASYS 180 MCG/ML VIALML, with a performance period through December 17, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC contract. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive federal contract portfolio with the DLA and other agencies demonstrates its critical role in supplying essential medical commodities to various government healthcare programs.
Generated 3/17/25, 10:04 AM